229 related articles for article (PubMed ID: 33644851)
1. Spliced HLA-bound peptides: a Black Swan event in immunology.
Faridi P; Dorvash M; Purcell AW
Clin Exp Immunol; 2021 May; 204(2):179-188. PubMed ID: 33644851
[TBL] [Abstract][Full Text] [Related]
2. A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands.
Faridi P; Li C; Ramarathinam SH; Vivian JP; Illing PT; Mifsud NA; Ayala R; Song J; Gearing LJ; Hertzog PJ; Ternette N; Rossjohn J; Croft NP; Purcell AW
Sci Immunol; 2018 Oct; 3(28):. PubMed ID: 30315122
[TBL] [Abstract][Full Text] [Related]
3. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
Levy R; Alter Regev T; Paes W; Gumpert N; Cohen Shvefel S; Bartok O; Dayan-Rubinov M; Alon M; Shmueli MD; Levin Y; Merbl Y; Ternette N; Samuels Y
Mol Cell Proteomics; 2023 Apr; 22(4):100519. PubMed ID: 36828127
[TBL] [Abstract][Full Text] [Related]
5. Nonclassical HLA-G molecules are classical peptide presenters.
Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
[TBL] [Abstract][Full Text] [Related]
6. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-Generated
Mansurkhodzhaev A; Barbosa CRR; Mishto M; Liepe J
Front Immunol; 2021; 12():614276. PubMed ID: 33717099
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.
Mylonas R; Beer I; Iseli C; Chong C; Pak HS; Gfeller D; Coukos G; Xenarios I; Müller M; Bassani-Sternberg M
Mol Cell Proteomics; 2018 Dec; 17(12):2347-2357. PubMed ID: 30171158
[TBL] [Abstract][Full Text] [Related]
9. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
[TBL] [Abstract][Full Text] [Related]
10. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
11. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
Vizcaíno JA; Kubiniok P; Kovalchik KA; Ma Q; Duquette JD; Mongrain I; Deutsch EW; Peters B; Sette A; Sirois I; Caron E
Mol Cell Proteomics; 2020 Jan; 19(1):31-49. PubMed ID: 31744855
[TBL] [Abstract][Full Text] [Related]
12. Peptide presentation and NK inhibition by HLA-G.
Münz C; Stevanović S; Rammensee HG
J Reprod Immunol; 1999 Jul; 43(2):139-55. PubMed ID: 10479050
[TBL] [Abstract][Full Text] [Related]
13. The role of peptide presentation in the physiological function of HLA-G.
Münz C; Nickolaus P; Lammert E; Pascolo S; Stevanović S; Rammensee HG
Semin Cancer Biol; 1999 Feb; 9(1):47-54. PubMed ID: 10092550
[TBL] [Abstract][Full Text] [Related]
14. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
15. The biogenesis of the immunopeptidome.
Admon A
Semin Immunol; 2023 May; 67():101766. PubMed ID: 37141766
[TBL] [Abstract][Full Text] [Related]
16. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
[TBL] [Abstract][Full Text] [Related]
17. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics.
Lim Kam Sian TCC; Goncalves G; Steele JR; Shamekhi T; Bramberger L; Jin D; Shahbazy M; Purcell AW; Ramarathinam S; Stoychev S; Faridi P
Front Immunol; 2023; 14():1107576. PubMed ID: 37334365
[TBL] [Abstract][Full Text] [Related]
18. HLA non-A,B,C class I genes: their structure and expression.
Heinrichs H; Orr HT
Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
[TBL] [Abstract][Full Text] [Related]
19. The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire.
Nicastri A; Liao H; Muller J; Purcell AW; Ternette N
Proteomics; 2020 Jun; 20(12):e1900401. PubMed ID: 32359108
[TBL] [Abstract][Full Text] [Related]
20. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
Li L; Batliwala M; Bouvier M
J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
